KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Sensus Healthcare, Inc.'s (SRTS) CEO Joseph Sardano on Q3 2021 Results - Earnings Call Transcript
Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 200.00% and 2.70%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the s
Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BOCA RATON, Fla, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and n
Fireside Chat with CEO Joe Sardano and CFO Javier Rampolla will be held October 19, 2021 at 11:00 a.m. ET Fireside Chat with CEO Joe Sardano and CFO Javier Rampolla will be held October 19, 2021 at 11
Premier gathering expected to host more than 1,200 physicians with 500 virtual participants is the first in-person dermatology medical conference in 18 months
Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q2 2021 Results - Earnings Call Transcript
BOCA RATON, Fla, July 29, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and n
Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q4 2020 Results - Earnings Call Transcript
BOCA RATON, Fla. , April 29, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological an
Sensus Healthcare stock fell to lows of $1.9 during 2020, from highs of >$9 in mid-2019, owing to a pandemic-induced collapse in annual sales from $27.3m to $9.6m in FY20. The company has developed Su
BOCA RATON, Fla, March 08, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a  medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effec
Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q4 2020 Results - Earnings Call Transcript
The stock price of Sensus Healthcare Inc (NASDAQ: SRTS) increased by 37.8% after hours as it went from a previous close of $3.81 to $5.25. This is why it happened.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE